査読有
doi：10.17998/jlc.2025.12.12
PubMed No.：41402036
種類：総説
誌名：Journal of Liver Cancer
発行年月：2025年12月
巻号頁：in press
論題：Strategic drug sequencing in hepatocellular carcinoma in the era of chemo-diversity: maximizing the therapeutic benefit of lenvatinib
著者：Hideki Iwamoto, Shigeo Shimose, Hironori Koga, Takumi Kawaguchi
